✦ LIBER ✦

A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates

✍ Scribed by Lisset Hermida; Lídice Bernardo; Jorge Martín; Mayling Alvarez; Irina Prado; Carlos López; Beatriz de la C. Sierra; Rafael Martínez; Rosmary Rodríguez; Aída Zulueta; Ana B. Pérez; Laura Lazo; Delfina Rosario; Gerardo Guillén; María G. Guzmán

Book ID: 116958723
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 229 KB
Volume: 24
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2006.01.036

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity and protective efficacy o

Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates

✍ Lidice Bernardo; Alienys Izquierdo; Mayling Alvarez; Delfina Rosario; Irina Prad 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 374 KB

Immunological evaluation in nonhuman pri

Immunological evaluation in nonhuman primates of formulations based on the chimeric protein P64k-domain III of dengue 2 and two components of Neisseria meningitidis

✍ Iris Valdés; Lisset Hermida; Jorge Martín; Tamara Menéndez; Lázaro Gil; Laura La 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 528 KB

Domain-III FG loop of the dengue virus t

Domain-III FG loop of the dengue virus type 2 envelope protein is important for infection of mammalian cells and Aedes aegypti mosquitoes

✍ Steven M. Erb; Siritorn Butrapet; Kelley J. Moss; Betty E. Luy; Thomas Childers; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 632 KB

A vaccine formulation consisting of nucl

A vaccine formulation consisting of nucleocapsid-like particles from Dengue-2 and the fusion protein P64k-domain III from Dengue-1 induces a protective immune response against the homologous serotypes in mice

✍ Laura Lazo; Lázaro Gil; Carlos López; Iris Valdés; Aracelys Blanco; Alequis Pavó 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 359 KB

Characterization of an antigenic site th

Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus

✍ Gregory D. Gromowski; Alan D.T. Barrett 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 994 KB

Recombinant, chimaeric live, attenuated

Recombinant, chimaeric live, attenuated vaccine (ChimeriVax™) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates

✍ T.P Monath; K Soike; I Levenbook; Z.-X Zhang; J Arroyo; S Delagrave; G Myers; A. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 165 KB